An observational study assessing the management of gastrointestinal and urogenital bleeding events in patients with atrial fibrillation treated with dabigatran etexilate (PRADAXA)
-
Sponsor: Boehringer Ingleheim
Location(s): United States
Description
This study is being conducted to collect data on the management of gastrointestinal and urogenital bleeding events occurring in patients with atrial fibrillation taking dabigatran etexilate.